Thursday, July 25, 2013
Publication and contact
Aurora kinase A (AURKA;
myelocytomatosis viral related oncogene neuroblastoma derived
culture and mouse studies suggest AURKA inhibitors that disrupt the
AURKA-NMYC complex could help treat neuroblastomas. In NMYC-driven
neuroblastoma cell lines, AURKA inhibitors decreased NMYC levels and
proliferation compared with vehicle. In a mouse model for aggressive
neuroblastoma, AURKA inhibitors decreased tumor NMYC levels and tumor volume
compared with vehicle. Next steps include identifying additional inhibitors
and testing combinations of existing AURKA inhibitors with alternative
NMYC-targeted compounds in neuroblastoma models.
Pharmaceuticals Inc. unit of Takeda
Pharmaceutical Co. Ltd. has alisertib,
a second-generation AURKA inhibitor, in Phase III testing to treat T cell
lymphoma. The compound also is in
Phase II and Phase I testing for other cancers.
At least six other companies have AURKA inhibitors in Phase II testing or
earlier to treat various cancers.
Published online July 25, 2013
Patented by Millennium
Pharmaceuticals; licensing status unavailable
M. et al. Cancer Cell;
published online June 20, 2013;
Contact: Martin Eilers, University of Wuerzburg, Wuerzburg,
Contact: Louis Chesler, The Institute of Cancer Research,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]